Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells (Q33337469)

25 July 2017

1 reference

title

Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells (English)

1 reference

25 July 2017

E V O'Loughlin

1

1 reference

PubMed ID

11377211

25 July 2017

R M Robins-Browne

series ordinal

2

1 reference

25 July 2017

1 May 2001

1 reference

25 July 2017

Microbes and Infection

1 reference

25 July 2017

3

1 reference

25 July 2017

6

1 reference

25 July 2017

493-507

1 reference

Diarrheagenic Escherichia coli

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The Pathogenesis of Shigella Diarrhea. V. Relationship of Shiga Enterotoxin, Neurotoxin, and Cytotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

PURIFICATION OF SHIGELLA DYSENTERIAE 1 (SHIGA)-LIKE TOXIN FROM ESCHERICHIA COLI 0157:H7 STRAIN ASSOCIATED WITH HAEMORRHAGIC COLITIS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Production of Shiga-Like Toxin by Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Roles of a ribosome-binding site and mRNA secondary structure in differential expression of Shiga toxin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

PREPARATION AND PROPERTIES OF SHIGA TOXIN AND TOXOID.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Effects of iron and temperature on Shiga-like toxin I production by Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Regulation of the Shiga-like toxin II operon in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Furin-induced cleavage and activation of Shiga toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Identification of the Shiga toxin A-subunit residues required for holotoxin assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Experimental verocytotoxemia in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

pH-independent retrograde targeting of glycolipids to the Golgi complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Translocation of Shiga toxin across polarized intestinal cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Modulation of host response to Escherichia coli o157:H7 infection by anti-CD18 antibody in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Intestinal permeability: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Do eicosanoids cause colonic dysfunction in experimental E coli O157:H7 (EHEC) infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Specific Interaction of Escherichia coli 0157:H7-Derived Shiga-like Toxin II with Human Renal Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Glomerular endothelial cell injury mediated by shiga-like toxin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin 2 promotes the stem cell differentiation into granulocytes in the bone marrow causing marked granulocytosis in the peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Verotoxin receptor glycolipid in human renal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Verotoxin-binding in human renal sections.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Plasma cytokine levels in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin induces medullary tubular injury in isolated perfused rat kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin 1 elicits diverse biologic responses in mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Shiga toxin-1 regulation of cytokine production by human proximal tubule cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Central nervous system manifestations of childhood shigellosis: prevalence, risk factors, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The association of Shiga toxin and other cytotoxins with the neurologic manifestations of shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Localization of verotoxin receptors in nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901405-8

7 January 2021

10.1016/S1286-4579(01)01405-8

Identifiers

DOI

1 reference

25 July 2017

1 reference

PubMed ID

11377211